A-shares open · 港股交易中 Quotes 行情 · 28 Sep 13:56 CST
28 Sep 2026 · 13:56 CST Terminal Access 终端入口 →
688271.SH上海证券交易所 · 科创板 STAR

Shanghai United Imaging Healthcare 联影医疗

Medical Devices 医疗器械
¥105.70+¥3.29 · +3.21%Live 实时 · 28 Sep 2026 · 13:56 CST · CNY
Open 开盘
¥102.77
High 最高
¥106.10
Low 最低
¥102.39
Prev Close 昨收
¥102.41
Volume 成交量
657.0万股
Turnover 成交额
¥6.87亿
Mkt Cap 总市值
¥871亿
P/E 市盈率
49.3×
Recent Activity 近期动态All Filings 全部公告 →

28 significant filings since 31 May 2026: 16 on equity incentive, 6 on buyback and 5 on dividend, and 1 other kind. The latest, on 3 Sep 2026: 联影医疗关于2026年半年度权益分派实施后调整回购价格上限的公告.
自 31 May 2026 起有 28 份重大公告:equity incentive 16 份、buyback 6 份、dividend 5 份,另有 1 类。最新一份(3 Sep 2026):联影医疗关于2026年半年度权益分派实施后调整回购价格上限的公告。

Price History 价格走势

22 trading days 个交易日 · High 最高 ¥108.45 · Low 最低 ¥100.30
102104106108
Volume 成交量
732.2万
26 Aug02 Sep09 Sep17 Sep24 Sep
Relative Value 同业比较
Medical Devices 医疗器械 · 140 listed peers
Measure 指标This Company 本公司Peer Median 同业中值Standing 排位
Market Cap 市值¥871亿¥47亿2nd highest of 140 · 140 家中第 2 高
Trailing P/E 市盈率49.3x40.2x43rd highest of 101 · 101 家中第 43 高
P/B 市净率4.0x2.3x27th highest of 140 · 140 家中第 27 高
Revenue Growth 营收增速17.2%4.0%34th highest of 140 · 140 家中第 34 高
Profit Growth 净利增速-10.1%-2.6%63rd lowest of 140 · 140 家中第 63 低
Gross Margin 毛利率47.2%55.2%55th lowest of 140 · 140 家中第 55 低
Net Margin 净利率12.6%10.7%61st highest of 140 · 140 家中第 61 高
Return on Equity 净资产收益率4.1%2.4%43rd highest of 140 · 140 家中第 43 高
Debt to Assets 资产负债率36.1%19.2%28th highest of 140 · 140 家中第 28 高
Grade Score 评级得分415243rd lowest of 140 · 140 家中第 43 低

Statement figures are for the period to 30 Jun 2026, filed by 140 of 140 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间,140 家同业中 140 家已披露。排位至少需要 5 家有数据的同业;无盈利的公司没有市盈率。

Largest Peers 主要同业
Peer 同业Market CapP/EP/BRevenue GrowthNet MarginROEGrade
Shenzhen Mindray Bio-Medical Electronics 迈瑞医疗¥1,917亿24.4x4.7x6.0%28.4%12.0%C
Shanghai United Imaging Healthcare 联影医疗¥871亿49.3x4.0x17.2%12.6%4.1%D
Shenzhen New Industries Biomedical 新产业¥388亿22.6x4.3x10.8%35.9%9.3%B
APT Medical 惠泰医疗¥341亿36.6x11.1x25.7%34.6%16.0%B
Wantai Biological 万泰生物¥334亿—2.8x24.3%-12.6%-1.1%D
Intco Medical Technology 英科医疗¥317亿27.9x1.7x40.6%13.1%4.5%C
MGI Tech 华大智造¥303亿—4.3x18.9%-11.6%-2.2%D
Andon Health 九安医疗¥274亿6.2x1.2x-30.6%578.7%13.7%C
IRAY Group 奕瑞科技¥262亿36.4x3.4x56.7%25.0%6.4%C
Jiangsu Yuyue Medical Equipment & Supply 鱼跃医疗¥262亿23.3x2.0x-1.9%18.6%6.2%C
Weigao Blood Purification 威高血净¥215亿43.7x1.8x-0.4%13.1%3.2%D
Lepu Medical Technology 乐普医疗¥210亿27.2x1.3x-4.6%14.2%3.0%D
Zhende Medical 振德医疗¥195亿70.6x3.4x5.9%6.8%2.5%D
Autobio 安图生物¥195亿19.6x2.2x-0.1%24.4%5.5%C

Peers are listed by market cap, with this company highlighted. 同业按市值排列,本公司高亮显示。